The project proposed herein is a methodology and synthetic investigation of the natural product cyclodidemniserinol trisulfate, a sulfated serinolipid that inhibits HIV-1 integrase.
The specific aims of the study are: 1) the use of a rhodium(II)-catalyzed tandem cyclization- cycloaddition reaction of an a-diazo carbonyl compound to generate stereoselectively the 6,8 dioxabicyclo[3.2.1]octane-ring system of cyclodidemniserinol trisulfate, 2) study the effects of pre-existing stereochemistry in the a-diazo carbonyl compound and the stereocenters influence on the facial selectivity in the 1,3-dipolar cycloaddition, 3) determine the absolute stereochemistry of the natural product, 4) and synthesize various diastereomer analogs. The synthesis of cyclodidemniserinol trisulfate and analogs will be beneficial to the study of the mechanism of action on HIV integrase and possibly lead to the discovery of new more potent HIV-1 integrase inhibitors.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32GM064027-02
Application #
6526098
Study Section
Medicinal Chemistry Study Section (MCHA)
Program Officer
Marino, Pamela
Project Start
2002-08-01
Project End
Budget Start
2002-08-01
Budget End
2003-07-31
Support Year
2
Fiscal Year
2002
Total Cost
$38,320
Indirect Cost
Name
Emory University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322